Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Miles Prince

Showing results (21-30 of 318) with videos related to

Pageof 32
Sort By:
Leukemia & Lymphoma|June 11, 2015
High-dose thiotepa-based conditioning regimens for relapsed lymphoma involving the central nervous system: from "orphan drug" to a standard-of-care?Carrie van der Weyden, H Miles Prince
Expert Review of Hematology|September 3, 2013
Romidepsin for peripheral T-cell lymphomaAmit Khot, Michael Dickinson, H Miles Prince
Blood|May 7, 2016
How I treat mycosis fungoides and Sézary syndromeSean Whittaker, Richard Hoppe, H Miles Prince
Expert Review of Hematology|June 15, 2011
Managing multiple myeloma in the elderly: are we making progress?Hang Quach, H Miles Prince, Andrew Spencer
Future Oncology (London, England)|December 4, 2013
Romidepsin for cutaneous T-cell lymphomaH Miles Prince, Michael Dickinson, Amit Khot
Drugs & Aging|September 28, 2007
Treatment strategies in elderly patients with multiple myeloma: current statusHang Quach, H Miles Prince, Linda Mileshkin
Leukemia & Lymphoma|February 28, 2007
An analysis of clinical trials assessing the efficacy and safety of single-agent thalidomide in patients with relapsed or refractory multiple myelomaH Miles Prince, Brad Schenkel, Linda Mileshkin
Leukemia & Lymphoma|February 26, 2008
The potential of histone deacetylase inhibitors for the treatment of multiple myelomaH Miles Prince, Mark Bishton, Simon Harrison
Leukemia & Lymphoma|April 10, 2008
The development of novel immunotherapeutic approaches in multiple myelomaStefan Peinert, H Miles Prince, Simon Harrison
Expert Opinion on Investigational Drugs|July 6, 2013
Panobinostat in lymphoid and myeloid malignanciesAmit Khot, Michael Dickinson, H Miles Prince
Pageof 32

Showing results (21-30 of 318) with videos related to

Sort By:
Pageof 32
Leukemia & Lymphoma|June 11, 2015
High-dose thiotepa-based conditioning regimens for relapsed lymphoma involving the central nervous system: from "orphan drug" to a standard-of-care?Carrie van der Weyden, H Miles Prince
Expert Review of Hematology|September 3, 2013
Romidepsin for peripheral T-cell lymphomaAmit Khot, Michael Dickinson, H Miles Prince
Blood|May 7, 2016
How I treat mycosis fungoides and Sézary syndromeSean Whittaker, Richard Hoppe, H Miles Prince
Expert Review of Hematology|June 15, 2011
Managing multiple myeloma in the elderly: are we making progress?Hang Quach, H Miles Prince, Andrew Spencer
Future Oncology (London, England)|December 4, 2013
Romidepsin for cutaneous T-cell lymphomaH Miles Prince, Michael Dickinson, Amit Khot
Drugs & Aging|September 28, 2007
Treatment strategies in elderly patients with multiple myeloma: current statusHang Quach, H Miles Prince, Linda Mileshkin
Leukemia & Lymphoma|February 28, 2007
An analysis of clinical trials assessing the efficacy and safety of single-agent thalidomide in patients with relapsed or refractory multiple myelomaH Miles Prince, Brad Schenkel, Linda Mileshkin
Leukemia & Lymphoma|February 26, 2008
The potential of histone deacetylase inhibitors for the treatment of multiple myelomaH Miles Prince, Mark Bishton, Simon Harrison
Leukemia & Lymphoma|April 10, 2008
The development of novel immunotherapeutic approaches in multiple myelomaStefan Peinert, H Miles Prince, Simon Harrison
Expert Opinion on Investigational Drugs|July 6, 2013
Panobinostat in lymphoid and myeloid malignanciesAmit Khot, Michael Dickinson, H Miles Prince
Pageof 32